A drug that uses a unique tactic to lessen the workload of the heart can help people with the chronic chest pain of angina when other medications fall short, a new study says.The drug, ranolazine, prevents heart cells from metabolizing fatty acids, their usual energy source. The cells then get their energy from glucose in a metabolic process that is easier on them. The result is improved exercise capacity and decreased pain.
